-
South Korea volleyball team latest to be bussed to wrong Games venue
-
Bears thrash Eagles 27-7 as third-string QB Keenum shines
-
Malaysia starts sending Myanmar migrants home
-
All Blacks name veteran Taylor captain as Mo'unga seizes 10 jersey
-
8.3 mn refugees at risk due to 'severe' funding cuts: UN
-
Race against time as Asian Games cricket quarter-finals washed out
-
Stocks drop and oil rises as Hormuz hopes fade
-
India turns to corals and seagrass to shield against rising seas
-
OpenAI cancels release of newest model due to safety concerns
-
Manchester City's Premier League charges: What comes next?
-
AI bosses head to White House as safety pressure builds
-
Brazil's cellphone crime: a security nightmare in every pocket
-
Batista sacked as Costa Rica coach after six months
-
Russia pummels Kyiv in latest deadly attack
-
Flooding, power cuts and evacuations as Hurricane Polo slams Mexico
-
NFL Giants obtain QB McCarthy from Vikings
-
Dodgers eye three-peat, Red Sox face Yankees as MLB playoffs begin
-
Deal for evicted Spanish pensioner as PM seeks new housing law
-
Certification of Boeing 737 MAX delayed by software bug
-
Clippers apologize, warn fans of 'challenges' after Leonard scandal
-
Celine Dion wows Paris Fashion Week with surprise gig
-
Turkish comedian convicted for Erdogan 'insult' freed pending appeal
-
AMD buys firm founded by AI 'godmother' Fei-Fei Li
-
Trump announces 'biggest' US steel plant in battleground Iowa
-
Italy rebound in Turkey as France win late in Belgium
-
Olise wonder strike gives Zidane's France win in Belgium
-
Pope says concerns about AI 'should be taken seriously'
-
US stocks fall, bond yields rise as Middle East war drags on
-
Hurricanes to hoist title banner as NHL season begins
-
Trump denies offering to sell arms to China's Xi
-
Justice Alito steps aside from major US climate case
-
Wemby ready for NBA Spurs to move rivals in climb to top
-
Willis happy with England exile after retains Top 14 player award
-
Ukraine to postpone some spending amid delays in aid: PM
-
Spain housing protests keep heat on government as PM seeks new law
-
Tuchel says Czech Republic game 'not yet a must-win'
-
Wissa spoils Zimbabwe homecoming as DR Congo win AFCON qualifier
-
MaXhosa puts South Africa on the Paris fashion map
-
UK police release on bail five men held over airbase incident
-
Rose, Scott among 2027 World Golf Hall of Fame finalists
-
Ex-All Black Plummer 'sure' New Zealand will find Super Rugby solution
-
Brunson says NBA champion Knicks can't get satisfaction
-
Shein sees 1% revenue growth in first half of 2026
-
France puts out largest wildfire since 1949
-
Netherlands regrets Israel retaliation in settlements row
-
Real Madrid's Perez summoned over Barcelona referee payments comments
-
Moscow seizes Russian assets of German food retailer Metro
-
Oil takes off again, Wall Street dips after Trump rejects Iran truce offer
-
Bulgarian spirits inflamed by new rakia rules
-
AlgoQuant Asset Management Selects Liquid Mercury to Enhance Digital Asset Trading Infrastructure
US Justice Dept taking abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The decision by President Joe Biden's administration came just hours after an appeals court rejected moves to ban mifepristone outright, but imposed a series of measures restricting access to the pill.
Mifepristone, which was approved by the Food and Drug Administration (FDA) in 2000 and accounts for more than half the abortions in the United States, has become the centerpiece of the country's latest clash over women's reproductive freedom.
Attorney General Merrick Garland said the Justice Department will be "seeking emergency relief from the Supreme Court to defend the FDA's scientific judgment and protect Americans' access to safe and effective reproductive care."
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone, also known as RU 486, should remain available pending a full hearing of the case, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the FDA's two-decades old approval of the drug last Friday.
- 'Furious' -
The appeals court said anti-abortion opponents had waited too long to challenge the drug's approval by the FDA but the judges' decision to impose restrictions on its use was denounced by groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
The anti-abortion group Susan B. Anthony described the appeals court ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over abortion rights comes nearly a year after the Supreme Court, where conservatives wield a 6-3 majority, overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
- 'Unborn human' -
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, seeking to impose a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
The Biden administration and leading pharmaceutical and biotech companies also argued that Kacsmaryk's ruling risked undermining the entire drug approval authority of the FDA.
"If this decision stands, no medication -- from chemotherapy drugs, to asthma medicine, to blood pressure pills, to insulin -- would be safe from attacks," said Vice President Kamala Harris.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access to the procedure -- or ban it outright.
A.Gasser--BTB